FindTrial
Sign In

A study to test the ability of Global Scale for Early Development (GSED) tools in detecting effects of a package of growth and development sensitive interventions on child neurodevelopment at 24 months of age

Use of the Global Scale for Early Development (GSED) within the Women and Infants Integrated Growth Study (WINGS) for Impact Evaluation on Neurodevelopment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/08/027228
Enrollment
1500
Registered
2020-08-18
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Centre for Health Research and Development Society for Applied Studies
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mother-child dyad who participated in primary WINGS trial (CTRI/2017/06/008908) and who consent to participate in this sub-study

Exclusion criteria

Exclusion criteria: Non-consent

Design outcomes

Primary

MeasureTime frame
1.Neurodevelopment scores using GSED tools at 6, 12 and 24 months 2.Predictive ability of GSED (measured at 12 months of age) for neurodevelopment scores measured at 24 months of age using GSED Timepoint: At 6, 12 and 24 months of child age—

Secondary

MeasureTime frame
1.Compare the BSID-III scores with the GSED scores at 24 months of child age 2.Compare the scores of the ASQ with those on the GSED scores at 6, 12, and 24 months Timepoint: 1. At 24 months of child age 2. At 6, 12 and 24 months of child age—

Countries

India

Contacts

Public ContactDr Ravi Prakash Upadhyay

Centre for Health Research and Development, Society for Applied Studies

ravi.upadhyay@sas.org.in011-46043751-55

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026